Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

NCT00185614 is registered in ClinicalTrials.gov with Wen-Kai Weng as lead sponsor.

NCT NCT00185614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
Lead sponsor
Wen-Kai Weng
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2000
Completion date
April 30, 2010
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, multiple myeloma